FindTrial
Sign In

A Recurrence Model for Patients with IASLC Grade II Invasive Lung Adenocarcinoma

High-Risk Recurrence Features in Patients with IASLC Grade II Invasive Lung Adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112725
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Case group:none

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed IASLC Grade II invasive lung adenocarcinoma and underwent radical surgical resection; 2. Complete clinical data available, including medical history, imaging studies, pathological reports, and treatment regimens; 3. Complete follow-up information documented.

Exclusion criteria

Exclusion criteria: 1. Concomitant malignancy of any other primary origin; 2. Incomplete clinical records or missing critical data elements; 3. Loss to follow-up or absence of post-operative surveillance data; 4. Severe systemic comorbidities (e.g., advanced cardiac, hepatic, or renal failure) that could confound outcome assessment.

Design outcomes

Primary

MeasureTime frame
5-year recurrence-free survival rate;Area Under the ROC curve;—

Secondary

MeasureTime frame
5-year survival rate;—

Countries

China

Contacts

Public Contacthanyue Li

Shanghai Chest Hospital

hanyue_li@hotmail.com+86 131 6227 1361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026